Erratum: Overexpression of Nrdp1 in the Heart Exacerbates Doxorubicin-Induced Cardiac Dysfunction in Mice (PLoS ONE (2011) 6:6 (e21104) DOI: 10.1371/journal.pone.0021104);Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Zhang, Yuan ^a   Kang, Yu Ming ^b   Tian, Cui ^c   Zeng, Yong ^d   Jia, Li Xin ^e   Ma, Xu ^f   Du, Jie ^e   Li, Hui Hua ^c  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DOXORUBICIN; GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NRDP1 PROTEIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CARRIER PROTEIN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 3; RNF41 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIOTOXICITY; CELL DEATH; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG TARGETING; ENZYME ACTIVATION; HEART; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; INFLAMMATION; MALE; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; DRUG EFFECT; ECHOCARDIOGRAPHY; GENETICS; HEART MUSCLE; HEART VENTRICLE; LIPID PEROXIDATION; METABOLISM; NICK END LABELING; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

ADENOVIRIDAE; MUS; MUS MUSCULUS; RATTUS;

ANIMALS; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CARRIER PROTEINS; DOXORUBICIN; ECHOCARDIOGRAPHY; HEART; HEART VENTRICLES; IN SITU NICK-END LABELING; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 79959612558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0267515     Document Type: Erratum

References (31)

1. Christiansen S, Autschbach R, (2006) Doxorubicin in experimental and clinical heart failure. Eur J Cardiothorac Surg 30: 611-616.
2. Teraoka K, Hirano M, Yamaguchi K, Yamashina A, (2000) Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats. Eur J Heart Fail 2: 373-378.
3. Sawyer DB, Fukazawa R, Arstall MA, Kelly RA, (1999) Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ Res 84: 257-265.
4. Riad A, Bien S, Gratz M, Escher F, Westermann D, et al. (2008) Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice. Eur J Heart Fail 10: 233-243.
5. Diamonti AJ, Guy PM, Ivanof C, Wong K, Sweeney C, et al. (2002) An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. Proc Natl Acad Sci U S A 99: 2866-2871.
6. Qiu XB, Goldberg AL, (2002) Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3. Proc Natl Acad Sci U S A 99: 14843-14848.
7. Yu F, Zhou J, (2008) Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced oxidative stress. Neurosci Lett 440: 4-8.
8. Zhong L, Tan Y, Zhou A, Yu Q, Zhou J, (2005) RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF regulates parkin stability and activity. J Biol Chem 280: 9425-9430.
9. Qiu XB, Markant SL, Yuan J, Goldberg AL, (2004) Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. Embo J 23: 800-810.
10. Wang C, Chen T, Zhang J, Yang M, Li N, et al. (2009) The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat Immunol 10: 744-752.
11. Camenisch TD, Schroeder JA, Bradley J, Klewer SE, McDonald JA, (2002) Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 8: 850-855.
12. Zhang Y, Zeng Y, Wang M, Tian C, Ma X, et al. (2011) Cardiac-specific overexpression of E3 ligase Nrdp1 increases ischemia and reperfusion-induced cardiac injury. Basic Res Cardiol 106: 371-383.
13. Fan GC, Yuan Q, Song G, Wang Y, Chen G, et al. (2006) Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1. Circ Res 99: 1233-1242.
14. Kizaki K, Ito R, Okada M, Yoshioka K, Uchide T, et al. (2006) Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice. Pharmacol Res 53: 341-346.
15. Kobayashi S, Volden P, Timm D, Mao K, Xu X, et al. (2010) Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. J Biol Chem 285: 793-804.
16. Martinet W, Agostinis P, Vanhoecke B, Dewaele M, De Meyer GR, (2009) Autophagy in disease: a double-edged sword with therapeutic potential. Clin Sci (Lond) 116: 697-712.
17. Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N, (2000) Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 207: 77-86.
18. Su HF, Samsamshariat A, Fu J, Shan YX, Chen YH, et al. (2006) Oleylethanolamide activates Ras-Erk pathway and improves myocardial function in doxorubicin-induced heart failure. Endocrinology 147: 827-834.
19. Jacoby JJ, Kalinowski A, Liu MG, Zhang SS, Gao Q, et al. (2003) Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci U S A 100: 12929-12934.
20. Taniyama Y, Walsh K, (2002) Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth. J Mol Cell Cardiol 34: 1241-1247.
21. Ferreira AL, Matsubara LS, Matsubara BB, (2008) Anthracycline-induced cardiotoxicity. Cardiovasc Hematol Agents Med Chem 6: 278-281.
22. Lim CC, Zuppinger C, Guo X, Kuster GM, Helmes M, et al. (2004) Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes. J Biol Chem 279: 8290-8299.
23. Kumarapeli AR, Horak KM, Glasford JW, Li J, Chen Q, et al. (2005) A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin. Faseb J 19: 2051-2053.
24. Riad A, Bien S, Westermann D, Becher PM, Loya K, et al. (2009) Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice. Cancer Res 69: 695-699.
25. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, et al. (2001) Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89: 168-173.
26. Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK, (1996) The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 98: 1253-1260.
27. Kang YJ, Chen Y, Epstein PN, (1996) Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 271: 12610-12616.
28. Xiang P, Deng HY, Li K, Huang GY, Chen Y, et al. (2009) Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol 63: 343-349.
29. Li HH, Kedar V, Zhang C, McDonough H, Arya R, et al. (2004) Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114: 1058-1071.
30. Xie P, Guo S, Fan Y, Zhang H, Gu D, et al. (2009) Atrogin-1/MAFbx Enhances Simulated Ischemia/Reperfusion-induced Apoptosis in Cardiomyocytes through Degradation of MAPK Phosphatase-1 and Sustained JNK Activation. J Biol Chem 284: 5488-5496.
31. Yang D, Zeng Y, Tian C, Liu J, Guo SB, et al. (2010) Transcriptomic analysis of mild hypothermia-dependent alterations during endothelial reperfusion injury. Cell Physiol Biochem 25: 605-614.